Global Nucleotide Market

Global Nucleotide Market Size, Share, Growth Analysis, By Type(Food Grade, Lab Grade), By Application(Pharmaceuticals, Food & beverage additive) - Industry Forecast 2024-2031


Report ID: SQMIG15B2089 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 64 | Figures: 75

Global Nucleotide Market News

  • On July 15, 2023, In order to create a nucleotide manufacturing plant in China for use in food and pharmaceutical applications, Kyowa Hakko Bio recently announced a new collaboration with WuXi AppTec.
  • On June 1, 2023, Partnered with Lonza, Star Lake Bioscience agreed to build a nucleotide production facility in the US that will serve the needs of the food and pharmaceutical industries.
  • On May 10, 2023, Meihua Group and DSM put a contract in place for the construction of a nucleotide production plant in China with a focus on the food and pharmaceutical industries.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Nucleotide Market size was valued at USD 595.72 million in 2022 and is poised to grow from USD 631.46 million in 2023 to USD 1006.46 million by 2031, growing at a CAGR of 6% during the forecast period (2024-2031).

The competitive landscape of the global nucleotide market is characterized by a blend of established players and emerging entrants striving to capitalize on the expanding applications of nucleotides across various industries. Major companies in the market are engaged in rigorous research and development activities to innovate and enhance their product portfolios, aiming to cater to the evolving needs of pharmaceutical, food and beverage, and diagnostic sectors. 'Thermo Fisher Scientific (US)', 'Merck KGaA (Germany)', 'Roche (Switzerland)', 'Agilent Technologies (US)', 'New England BioLabs (US)', 'Takara Bio (Japan)', 'Bio-Rad Laboratories (US)', 'Lonza Group (Switzerland)', 'Promega Corporation (US)', 'QIAGEN (Germany)', 'Creative BioMart (China)', 'Bioss (China)', 'GenScript (China)', 'BioVision (US)', 'Eurofins Scientific (France)', 'Enzo Biochem (US)', 'SERVA Electrophoresis (Germany)', 'IDT (US)', 'Life Technologies (US)', 'Sigma-Aldrich (US)'

The global nucleotide market is propelled by the continuous advancements in pharmaceutical research and development. Nucleotides play a crucial role in drug discovery, gene therapies, and personalized medicine, driving their demand in the pharmaceutical industry.

Rising Demand for Natural Ingredients: Consumer’s preference for natural and clean-label ingredients is driving the trend of using nucleotides derived from natural sources. Manufacturers are focusing on sourcing nucleotides from sustainable and organic origins.

In North America, the nucleotide market is experiencing robust expansion propelled by the region's well-established pharmaceutical and biotechnology sectors. The increasing emphasis on personalized medicine and advancements in diagnostic research are pivotal drivers behind the heightened demand for nucleotides. Moreover, growing consumer awareness regarding the advantages of nucleotide-based flavor enhancers within the food and beverage industry further fortifies the market's growth. Regulatory frameworks that foster innovation and research activities also bolster North America's standing in the nucleotide market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Nucleotide Market

Product ID: SQMIG15B2089

$5,300
BUY NOW GET FREE SAMPLE